Sort
15,440 grants matching “organoids”
Project-004
$214,580Lori L Isom · University Of Michigan At Ann Arbor · U54 · FY2022 · NS
Mechanisms of antiviral immunity and tolerance in the intestinal epithelium of Jamaican Fruit Bats
$214,575Diane Bimczok · Montana State University - Bozeman · R21 · FY2023 · AI
Novel Antibody-Drug Conjugate Combination Therapy for Treating Colorectal Cancer
$214,414Kendra S. Carmon · University Of Texas Hlth Sci Ctr Houston · R21 · FY2023 · CA
The Bioimaging Core
$214,057Kenneth P Olive · Columbia University Health Sciences · P30 · FY2025 · DK
An Intestinal Helminth Promotes Enteric Viral Infection Independent of Type 2 Immunity
$214,006Jakob H. Von Moltke · University Of Washington · R21 · FY2025 · AI
Core D: Preclinical Models Core
$213,993Yu Chen · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Core E:Biomarkers Core
$213,993Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Development of in vitro human spinal neural tube model to study genetic and environmental etiology of Spina Bifida.
$213,945Sung Eun Kim · University Of Texas At Austin · R21 · FY2024 · HD
nbInnate Immunity Responses In Monocytes: Contribution To Neurodegeneration
$213,923Yisel M. Cantres-Rosario · University Of Puerto Rico Med Sciences · K22 · FY2023 · NS
nbInnate Immunity Responses In Monocytes: Contribution To Neurodegeneration
$213,923Yisel M. Cantres-Rosario · University Of Puerto Rico Med Sciences · K22 · FY2025 · NS
nbInnate Immunity Responses In Monocytes: Contribution To Neurodegeneration
$213,923Yisel M. Cantres-Rosario · University Of Puerto Rico Med Sciences · K22 · FY2024 · NS
APC + TP53 Combinatorial Mutations Emerging as Biomarkers to Predict EGFRI Sensitivity
$213,881Timothy J Yeatman · University Of Utah · R21 · FY2021 · CA
Repurposing Auranofin As a Novel Notch Pathway Inhibitor for Combinational Ovarian Cancer Therapy
$213,881Hua-Ying Fan · University Of New Mexico Health Scis Ctr · R21 · FY2024 · CA
3D biomimetic image-based stromal models of pancreatic cancer for drug screening
$213,829Paul J. Campagnola · University Of Wisconsin-Madison · R21 · FY2018 · CA
Tissue Analysis & Molecular Imaging Core
$213,821Jason C Mills · Baylor College Of Medicine · P30 · FY2025 · DK
Tissue Analysis & Molecular Imaging Core
$213,821Jason C Mills · Baylor College Of Medicine · P30 · FY2024 · DK
Impact of CLDN1 inhibition on chemoresistance and metastasis of colon cancer
$213,771Punita Dhawan · University Of Nebraska Medical Center · R01 · FY2024 · CA
Microbial contributions to the metabolic changes after Roux-en-Y gastric bypass
$213,750Lee Michael Kaplan · Massachusetts General Hospital · R21 · FY2018 · DK
Core C: Sphingolipid Cancer Animal Pathology Core
$213,680Ashley Jones Snider · State University New York Stony Brook · P01 · FY2022 · CA
Androgen and Wnt signaling in bladder cancer
$213,653Liang Ma · Washington University · R21 · FY2023 · CA
Developing Acute Myeloid Leukemia Models with Diverse Ancestral Origins
$213,594Timothy Sebastian Pardee · Wake Forest University Health Sciences · R21 · FY2024 · CA
TMPRSS2-ERG chromosomal translocations and prostate cancer
$213,477Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Project 2 - The determinants of rotavirus host range restriction in human intestines
$213,401Harry Bernard Greenberg · Stanford University · U19 · FY2015 · AI
Characterization of metastasis models derived from breast cancer patients of African descent
$213,383Joshua (chuck) Harrell · Virginia Commonwealth University · R21 · FY2023 · CA
Resveratrol-mediated regulation of inflammatory pathways in Autism spectrum disorders
$213,375Sofia Beatriz Lizarraga · University Of South Carolina At Columbia · P20 · FY2020 · GM